Indications
Indicated for the treatment of adults with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Composition
- Active substance
- avacincaptad pegol
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Izelvay
- Active substance
- avacincaptad pegol
- ATC code
- S01XA32
- Group
- Sensory organs
- Therapeutic area
- Macular Degeneration, Geographic Atrophy
- Marketing authorisation holder
- Astellas Pharma Europe B.V.
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/006153